Nano cap Cassava Sciences (NASDAQ:SAVA) is up 25% after hours on robust volume in apparent response to stock purchases by President & CEO Remi Barbier.
On December 18 he bought 2,599 shares at $1.65, 10K shares at $4.15 on December 26 and 100K shares at $5.53 today.
The stock rallied more than 250% in December stoked by encouraging data on Alzheimer’s candidate PTI-125.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.